Bone Metastasis Clinical Trial
Official title:
Magnetic Resonance-guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases - a Multicenter Study
The purpose of this study is to evaluate the effectiveness of the Philips Sonalleve Magnetic Resonance Imaging-guided High Intensity Focused Ultrasound (MR-HIFU) device for treating painful bone metastases.
Magnetic Resonance Imaging-guided High Intensity Focused Ultrasound (MR-HIFU) is a
non-invasive outpatient modality. In MR-HIFU, a specially designed ultrasound transducer is
used to focus a beam of ultrasound energy into a small volume at a specific target site in
the body. The focused beam is intended to produce therapeutic hyperthermia in the target
field while only harmlessly warming the immediately surrounding tissue. Magnetic Resonance
Imaging is used during the ultrasound treatment, both to focus the ultrasound beam on the
target field and to perform real-time thermal mapping at and around the target.
The Philips Sonalleve MR-HIFU system is expected to be efficacious in reducing pain scores
in patients with painful bone metastases and in reducing their pain medication usage.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01833806 -
A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
|
N/A | |
| Completed |
NCT02609828 -
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
|
Phase 3 | |
| Completed |
NCT04592887 -
Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|
N/A | |
| Recruiting |
NCT02231476 -
Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients
|
Phase 2 | |
| Recruiting |
NCT02426697 -
Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
|
Phase 3 | |
| Completed |
NCT00334139 -
Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer
|
Phase 4 | |
| Completed |
NCT01784393 -
Chemoradiation for Bone Metastasis
|
Phase 2 | |
| Terminated |
NCT02999152 -
Validation of Radio-induced Damage Biomarkers
|
N/A | |
| Not yet recruiting |
NCT02480634 -
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
|
Phase 4 | |
| Completed |
NCT02784652 -
Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors
|
Phase 2 | |
| Completed |
NCT02673060 -
A Trial of MBC-11 in Patients With CIBD
|
Phase 1 | |
| Completed |
NCT02774213 -
A Study to Collect Data About Analgesia in Patients With Bone Metastasis
|
||
| Completed |
NCT02876731 -
Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)
|
N/A | |
| Recruiting |
NCT02705157 -
The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
|
N/A | |
| Completed |
NCT01309048 -
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases
|
Phase 1/Phase 2 | |
| Completed |
NCT01062503 -
Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC
|
N/A | |
| Completed |
NCT00610272 -
Optimization of Radiotherapy in Treatment of Painful Bone Metastasis
|
Phase 3 | |
| Completed |
NCT01998607 -
Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw
|
N/A | |
| Recruiting |
NCT02876991 -
Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
|
N/A | |
| Completed |
NCT02293642 -
Bone Pain Score Validation Initiative
|